T1	Participants 350 443	Fifty-seven patients scheduled for transurethral resection of the prostate or a vesical tumor
T2	Participants 445 607	Patients were ASA I-III, over 55 years of age and randomly assigned to two groups to receive 5% prilocaine (1 mg/kg, n = 27) or 2% mepivacaine (0.8 mg/kg, n = 30)
T3	Participants 27 113	5% prilocaine and 2% mepivacaine by the subarachnoid route in transurethral resections
T4	Participants 1158 1308	Five cases of hypotension and 4 of bradycardia occurred in each group and one patient in the mepivacaine group suffered slight postoperative cephalea.
